Cubist Systematic Strategies’s CME Group CME Stock Holding History

Cubist Systematic Strategies’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.19M	Buy	19,200 +2,600	+16%	+$707K	0.02%	943
2025 Q2	$4.58M	Buy	+16,600	New	+$4.51M	0.02%	1066
2024 Q4	–	Sell	-2,100	Closed	-$463K	–	3044
2024 Q3	$463K	Hold	2,100	–	–	﹤0.01%	2242
2024 Q2	$413K	Sell	2,100 -16,400	-89%	-$3.39M	﹤0.01%	2221
2024 Q1	$3.98M	Buy	18,500 +3,100	+20%	+$651K	0.02%	1111
2023 Q4	$3.24M	Buy	15,400 +11,700	+316%	+$2.5M	0.02%	1140
2023 Q3	$741K	Sell	3,700 -13,900	-79%	-$2.76M	0.01%	2076
2023 Q2	$3.26M	Sell	17,600 -10,400	-37%	-$1.92M	0.02%	1111
2023 Q1	$5.36M	Sell	28,000 -65,600	-70%	-$11.9M	0.03%	868
2022 Q4	$15.7M	Buy	93,600 +59,900	+178%	+$10.4M	0.09%	256
2022 Q3	$5.97M	Buy	33,700 +29,600	+722%	+$5.85M	0.03%	905
2022 Q2	$839K	Buy	+4,100	New	+$869K	0.01%	2613

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cubist Systematic Strategies's CME Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its CME Group (CME) stake by 33% in Q3 2025, selling an estimated $10M and leaving 75,000 shares worth $20.3M. The position accounts for 0.1% of the portfolio, ranked #276.

Cubist Systematic Strategies first reported a position in CME in Q2 2014 and has held it in 45 quarters since. The position peaked at $60.2M in Q2 2024. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

Cubist Systematic Strategies held 75,000 shares of CME Group worth $20.3M as of Q3 2025.
Cubist Systematic Strategies sold 36,817 CME Group shares in Q3 2025, an estimated $10M.
CME Group made up 0.1% of Cubist Systematic Strategies's portfolio in Q3 2025, its #276 holding.
Cubist Systematic Strategies first reported a position in CME Group in Q2 2014 and has held it in 45 quarters since.
Cubist Systematic Strategies's CME Group position peaked at $60.2M in Q2 2024.
1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.